Chronos Archive seal
The Human Record

Hatshepsut

Case HR-AC006 · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
About 1507 BC (very uncertain; no source records the year) – About 1458 BC (year 22 of Thutmose III; the date varies by chronology)
Synthetic DOB
1978-02-10
Index visit
2026-04-14 at age 48
Synthetic MRN
HR-AC006-SYN

Teaching objective: Care for a 48-year-old woman with a painful swollen jaw from a dental abscess, and type 2 diabetes found on screening, as current guidance advises and without weight stigma: recognize the warning signs of spreading odontogenic infection; give an NSAID with acetaminophen for dental pain and no opioid; withhold antibiotics when the abscess is localized, there is no systemic involvement and definitive treatment is available the next day (ADA 2019); arrange urgent drainage and extraction; diagnose diabetes from two abnormal results in one sample; start metformin, then add a GLP-1 receptor agonist chosen for weight and glucose (ADA Standards of Care 2026), with an SGLT2 inhibitor not indicated without kidney or heart disease; start a statin as the Standards advise for adults 40 to 75 with diabetes; screen for eye, foot and kidney complications; explain the two-way link between periodontitis and diabetes and arrange periodontal therapy; manage knee osteoarthritis with exercise and a topical NSAID; and keep up cancer screening by age (mammography, colorectal and cervical) and bone health, without a search for bone cancer when nothing in the modern episode points to one. The modern episode is a teaching case, not a claim about her real illnesses, which cannot be known from ancient remains whose identity is debated.

Historical timeline

DateEventClaims
About 1507 BC (very uncertain)Born, daughter of Thutmose I; the year is a rough estimate.CLM-0005, CLM-0001, CLM-0003
About 1479 BCOn the death of Thutmose II, regent for the young Thutmose III.CLM-0002
About 1473 BC (year 7 of Thutmose III)Rules as king, jointly with Thutmose III.CLM-0002
About 1458 BC (year 22 of Thutmose III)Dies; cause unknown.CLM-0004
No earlier than about 1438 BC (year 42 of Thutmose III)Her monuments begin to be effaced and recarved.CLM-0006
2007Mummy KV60A announced as hers; CT findings reported; the identification is debated.CLM-0007, CLM-0008, CLM-0009, CLM-0010, CLM-0011
2011University of Bonn reports a carcinogen in a lotion flask bearing her name.CLM-0012

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Hatshepsut was a daughter of the king Thutmose I and became the chief queen of Thutmose II.
History only.
confirmed Dorman PF. Hatshepsut: Wicked Stepmother or Joan of Arc? Oriental Institute News and Notes 168 (Winter 2001) supports
D After the death of Thutmose II she acted as guardian and regent for the young Thutmose III, her nephew and stepson; by his seventh regnal year she had taken the public role of a king, while still referred to with feminine forms.
Anchors her modern role as the head of a large public authority.
confirmed Dorman PF. Hatshepsut: Wicked Stepmother or Joan of Arc? Oriental Institute News and Notes 168 (Winter 2001) supports
D She claimed to have been born of a union between her mother and the god Amun-Ra, and looked to her father Thutmose I as the source of her kingship.
History only.
confirmed Egypt and Sudan Newsletter 1 (2014): Pharaoh: King of Egypt supports
Dorman PF. Hatshepsut: Wicked Stepmother or Joan of Arc? Oriental Institute News and Notes 168 (Winter 2001) supports
D Her dates follow different chronologies: The Metropolitan Museum of Art dates objects of her joint reign with Thutmose III to about 1473 to 1458 BCE, and the British Museum gives her dates as 1479 to 1457 BC. She died in the twenty-second regnal year of Thutmose III.
Dates are approximate; the record uses about 1458 BC for her death.
probable Seated Statue of Hatshepsut (Rogers Fund, 1929), collection record: ca. 1473–1458 BCE, joint reign of Hatshepsut and Thutmose III, Dynasty 18, New Kingdom supports
Egypt and Sudan Newsletter 1 (2014): Pharaoh: King of Egypt supports
Dorman PF. Hatshepsut: Wicked Stepmother or Joan of Arc? Oriental Institute News and Notes 168 (Winter 2001) supports
HISTMED Master Roster v3 context
R Her birth year is not recorded. An age of about 50 at death, suggested by study of the mummy identified as hers, would place her birth about 1507 BC; this is a rough estimate.
Used only to set an approximate, very uncertain birth year.
possible Rose M. Hatshepsut Found; Thutmose I Lost supports
HISTMED Master Roster v3 context
D No earlier than the forty-second year of Thutmose III, at least twenty years after her death, a program began to efface and recarve her monuments.
History only.
confirmed Dorman PF. Hatshepsut: Wicked Stepmother or Joan of Arc? Oriental Institute News and Notes 168 (Winter 2001) supports
D In 2007 Zahi Hawass announced that KV60A, the mummy of an obese woman left on the floor of tomb KV60 in the Valley of the Kings, was Hatshepsut. The identification rested on CT scans, above all on a molar found in a small chest inscribed with her name from the royal cache DB320, which fitted a gap in KV60A's jaw where only one root of a molar remained.
Documents the announcement and its basis, not the identity itself.
confirmed Rose M. Hatshepsut Found; Thutmose I Lost supports
R The identification is debated: any link between these mummies and the inscribed chest is uncertain, the consensus cited is that the tooth probably broke after death rather than being extracted in life, the DNA results were preliminary, and identifications of royal mummies of this dynasty are often unclear.
Every finding on KV60A may not be hers.
disputed Rose M. Hatshepsut Found; Thutmose I Lost supports
Habicht ME, Bouwman AS, Rühli FJ. Identifications of ancient Egyptian royal mummies from the 18th Dynasty reconsidered. Am J Phys Anthropol 2016;159(Suppl 61):S216-S231 (PMID 26808107) supports
R The CT scans of KV60A were reported to show a woman of about 50, about five feet tall and greatly overweight, with severe dental disease (missing teeth, root remnants, bone eroded at root tips by infection, and severe gum disease), and osteoarthritis and osteoporosis; a burst abscess with spreading infection was suggested as a cause of death.
Findings on remains whose identity is debated, reported in a magazine and a documentary fact sheet rather than a peer-reviewed paper. Not linked to the modern episode, which is set before her death.
possible Rose M. Hatshepsut Found; Thutmose I Lost supports
R A lesion in the left iliac bone of KV60A was read by the radiologist Ashraf Selim as more likely a metastatic deposit from another cancer than a primary bone tumour, which could not be totally excluded.
Retrospective; no cancer is diagnosed in the modern episode.
possible Rose M. Hatshepsut Found; Thutmose I Lost supports
R Diabetes has been proposed for KV60A on circumstantial grounds; the radiologist called it a theory that cannot be confirmed.
Retrospective; the modern diabetes is a synthetic screening finding, not linked to this claim.
disputed Rose M. Hatshepsut Found; Thutmose I Lost supports
R In 2011 the University of Bonn reported that a flask in its Egyptian Museum inscribed with her name held the dried residue of a skin lotion or medication (palm oil, nutmeg apple oil, unsaturated fatty acids and hydrocarbons from creosote and asphalt), including benzo(a)pyrene, a strong carcinogen, and suggested that she may have exposed herself to it over years.
A hypothesis from a press release; no study is cited, and the flask's use by her is inferred.
possible Deadly medication? (University of Bonn press release) supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Painful swelling of the left lower jaw for four days, after a throbbing toothache for three weeks under a broken lower left molar; low-grade temperature, no trismus, no swelling of the floor of the mouth or neck; dental abscess suspected resolved confirmed active
S Acute periapical abscess of the lower left first molar (tooth 19), non-restorable, with a localized buccal vestibular swelling and no spread to fascial spaces; drained and extracted resolved confirmed active
S Type 2 diabetes found on screening (hemoglobin A1c 7.6% with a random glucose of 212 mg/dL from the same sample), with thirst and waking at night to pass urine; normal kidney function and urine albumin active confirmed active
S Obesity, class 2 (BMI 36.3), with type 2 diabetes and knee osteoarthritis; she wants to feel stronger and move more easily active confirmed active
S Primary osteoarthritis of both knees: pain on stairs and after standing, morning stiffness under 30 minutes, crepitus, no effusion; a clinical diagnosis without imaging active confirmed active
S Periodontitis, generalized, stage III, grade C (bone loss to the middle third of the roots, two molars lost earlier to gum disease, and A1c above 7% as a grade modifier) active confirmed active
S Acute uncomplicated cystitis (dysuria and frequency for two days, urine dipstick positive for leukocyte esterase and nitrite, no fever or flank pain); urine culture grew Escherichia coli sensitive to nitrofurantoin; resolved resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2026-04-14 Hemoglobin [Mass/volume] in Blood 13.1 g/dL
Reference 11.7-15.5 g/dL
http://loinc.org · 718-7
S 2026-04-14 Leukocytes [#/volume] in Blood by Automated count 11.6 10*3/uL (high)
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 2026-04-14 Platelets [#/volume] in Blood by Automated count 312 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-04-14 Sodium [Moles/volume] in Serum or Plasma 137 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-04-14 Potassium [Moles/volume] in Serum or Plasma 4.2 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-04-14 Urea nitrogen [Mass/volume] in Serum or Plasma 13 mg/dL
Reference 7-20 mg/dL
http://loinc.org · 3094-0
S 2026-04-14 Creatinine [Mass/volume] in Serum or Plasma 0.72 mg/dL
Reference 0.5-1.1 mg/dL
http://loinc.org · 2160-0
S 2026-04-14 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 103 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-04-14 Glucose [Mass/volume] in Serum or Plasma 212 mg/dL (high)
Reference 70-139 mg/dL
http://loinc.org · 2345-7
S 2026-04-14 Calcium [Mass/volume] in Serum or Plasma 9.4 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 2026-04-14 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 2026-04-14 Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 84 U/L
Reference 35-104 U/L
http://loinc.org · 6768-6
S 2026-04-14 Hemoglobin A1c/Hemoglobin.total in Blood 7.6% (high)
Reference Below 5.7% is normal; 6.5% or more is diabetes; goal below 7% for most adults with diabetes
http://loinc.org · 4548-4
S 2026-04-14 Cholesterol [Mass/volume] in Serum or Plasma 214 mg/dL (high)
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 2026-04-14 Cholesterol in HDL [Mass/volume] in Serum or Plasma 44 mg/dL (low)
Reference >=50 mg/dL
http://loinc.org · 2085-9
S 2026-04-14 Triglyceride [Mass/volume] in Serum or Plasma 210 mg/dL (high)
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 2026-04-14 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 128 mg/dL
Reference Goal below 100 mg/dL in diabetes, below 70 mg/dL at higher risk
http://loinc.org · 13457-7
S 2026-04-14 Albumin/Creatinine [Mass Ratio] in Urine 18 mg/g{creat}
Reference <=29 mg/g{creat}
http://loinc.org · 9318-7
S 2026-04-14 Thyrotropin [Units/volume] in Serum or Plasma 2.1 mIU/L
Reference 0.4-4.5 mIU/L
http://loinc.org · 3016-3
S 2026-04-14 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 http://loinc.org · 44261-6
S 2026-04-14 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 3 http://loinc.org · 70274-6
S 2026-07-21 Hemoglobin A1c/Hemoglobin.total in Blood 6.6% (high)
Reference Below 5.7% is normal; 6.5% or more is diabetes; goal below 7% for most adults with diabetes
http://loinc.org · 4548-4
S 2026-07-21 Cholesterol [Mass/volume] in Serum or Plasma 152 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 2026-07-21 Cholesterol in HDL [Mass/volume] in Serum or Plasma 48 mg/dL (low)
Reference >=50 mg/dL
http://loinc.org · 2085-9
S 2026-07-21 Triglyceride [Mass/volume] in Serum or Plasma 140 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 2026-07-21 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 76 mg/dL
Reference Goal below 100 mg/dL in diabetes, below 70 mg/dL at higher risk
http://loinc.org · 13457-7
S 2026-07-21 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 27 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 2026-07-21 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 http://loinc.org · 44261-6
S 2026-06-30 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 2026-06-30 Total score [AUDIT-C] 1 http://loinc.org · 75626-2

Synthetic vital signs

DateMeasureResultLOINCGrade
2026-04-14Body height160 cm8302-2S
2026-04-14Body weight93 kg29463-7S
2026-04-14Body mass index (BMI) [Ratio]36.3 kg/m239156-5S
2026-04-14Systolic blood pressure128 mm[Hg]8480-6S
2026-04-14Diastolic blood pressure82 mm[Hg]8462-4S
2026-04-14Heart rate92 /min8867-4S
2026-04-14Respiratory rate16 /min9279-1S
2026-04-14Body temperature37.6 Cel8310-5S
2026-04-14Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-04-15Body height160 cm8302-2S
2026-04-15Body weight92.8 kg29463-7S
2026-04-15Body mass index (BMI) [Ratio]36.2 kg/m239156-5S
2026-04-15Systolic blood pressure126 mm[Hg]8480-6S
2026-04-15Diastolic blood pressure80 mm[Hg]8462-4S
2026-04-15Heart rate88 /min8867-4S
2026-04-15Respiratory rate16 /min9279-1S
2026-04-15Body temperature37.4 Cel8310-5S
2026-04-15Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-05-26Body height160 cm8302-2S
2026-05-26Body weight91.5 kg29463-7S
2026-05-26Body mass index (BMI) [Ratio]35.7 kg/m239156-5S
2026-05-26Systolic blood pressure124 mm[Hg]8480-6S
2026-05-26Diastolic blood pressure78 mm[Hg]8462-4S
2026-05-26Heart rate78 /min8867-4S
2026-05-26Respiratory rate14 /min9279-1S
2026-05-26Body temperature36.7 Cel8310-5S
2026-05-26Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-07-21Body height160 cm8302-2S
2026-07-21Body weight88.6 kg29463-7S
2026-07-21Body mass index (BMI) [Ratio]34.6 kg/m239156-5S
2026-07-21Systolic blood pressure120 mm[Hg]8480-6S
2026-07-21Diastolic blood pressure76 mm[Hg]8462-4S
2026-07-21Heart rate74 /min8867-4S
2026-07-21Respiratory rate14 /min9279-1S
2026-07-21Body temperature36.6 Cel8310-5S
2026-07-21Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-06-23Body height160 cm8302-2S
2026-06-23Body weight90.4 kg29463-7S
2026-06-23Body mass index (BMI) [Ratio]35.3 kg/m239156-5S
2026-06-23Systolic blood pressure122 mm[Hg]8480-6S
2026-06-23Diastolic blood pressure78 mm[Hg]8462-4S
2026-06-23Heart rate84 /min8867-4S
2026-06-23Respiratory rate16 /min9279-1S
2026-06-23Body temperature37.2 Cel8310-5S
2026-06-23Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-06-30Body height160 cm8302-2S
2026-06-30Body weight90 kg29463-7S
2026-06-30Body mass index (BMI) [Ratio]35.2 kg/m239156-5S
2026-06-30Systolic blood pressure120 mm[Hg]8480-6S
2026-06-30Diastolic blood pressure78 mm[Hg]8462-4S
2026-06-30Heart rate76 /min8867-4S
2026-06-30Respiratory rate14 /min9279-1S
2026-06-30Body temperature36.6 Cel8310-5S
2026-06-30Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
Dental infection drained and the tooth removed within 24 hours, with no spread of infection2026-04-15completedDrained and extracted the next day; no spread
Hemoglobin A1c below 7% within four months2026-07-21completedA1c 6.6% at fourteen weeks
LDL cholesterol below 100 mg/dL on a statin2026-07-21completedLDL 76 mg/dL on atorvastatin
Periodontal therapy completed and three-monthly maintenance arranged2026-07-21completedScaling and root planing completed; maintenance every three months
Climb stairs at the building sites with less knee pain, and walk 150 minutes a week2026-07-21activeWalking about 120 minutes a week; knee pain on stairs eased

Interventions

InterventionStatusGuideline
Dental pain and infection safety today: ibuprofen 400 mg with acetaminophen 1 g, alternating, for up to a week, and no opioid; no antibiotic, because the swelling is localized, there is no fever above 38 °C, no trismus and no spread, and drainage is arranged within 24 hours; go to the emergency department at once for swelling spreading to the eye, the floor of the mouth or the neck, difficulty swallowing or breathing, trouble opening the mouth, or a fevercompletedGL-ADA-DENT-PAIN-2024, GL-ADA-DENT-ABX-2019
Urgent oral and maxillofacial surgery consultation within 24 hours for imaging, drainage of the abscess and extraction or other definitive treatment of the broken molar, with an assessment of her gumscompletedGL-ADA-DENT-ABX-2019, GL-EFP-IDF-2018
Type 2 diabetes: metformin extended-release, started slowly; diabetes self-management education and medical nutrition therapy in the clinic's program; A1c every three months until at goal; eye screening, a comprehensive foot examination and kidney tests at diagnosis and yearly; blood pressure goal below 130/80; sick-day rules for metformin; endocrinology only if the A1c is not at goal by six monthscompletedGL-ADA-2026, GL-CMID-2026
Weight and health without stigma: person-first language, weight discussed only with her permission, goals she sets for strength and movement, and the medicines that lower both glucose and weight (GLP-1 receptor agonists) explained for her to considercompletedGL-ADA-OB-2026
Knee osteoarthritis: a walking and strengthening program, diclofenac gel as needed, and a cane or knee support for long site visits if helpful; no imaging needed for a clinical diagnosiscompletedGL-ACR-OA-2019, GL-CMID-2026
Mood screening: PHQ-9 and GAD-7 at intake and at the end of the episodecompletedGL-USPSTF-DEP-2023
Periodontitis and the abscess: chlorhexidine rinse for two weeks after the extraction; scaling and root planing of all teeth by the dental team about six weeks after the extraction, then periodontal maintenance every three months; the two-way link with diabetes explained (periodontal treatment can lower A1c, and better glucose control helps the gums heal)completedGL-EFP-IDF-2018, GL-AAP-EFP-2018
Semaglutide once weekly, 0.25 mg for four weeks, then 0.5 mg, with small meals and stopping eating when full to limit nausea; chosen with her for glucose and weight after the dental infection had settled; an SGLT2 inhibitor is not indicated without kidney or heart disease; muscle-strengthening exercise and enough protein to protect muscle and bone as weight fallscompletedGL-ADA-2026, GL-ADA-OB-2026
Cardiovascular risk: atorvastatin 20 mg daily (moderate intensity), as advised for adults 40 to 75 with diabetes; lipids and ALT at about eight to twelve weekscompletedGL-ADA-CV-2026, GL-CMID-2026
Acute cystitis: nitrofurantoin for five days after a urine culture; fluids; metformin continued while she eats and drinks normally, and paused if she vomits or cannot keep fluids down; the semaglutide step up to 0.5 mg delayed one week; return at once for fever, flank pain, vomiting or symptoms not better in 48 hourscompletedGL-IDSA-CYSTITIS-2011, GL-ADA-2026
Cancer screening by age: screening mammography (every two years from 40), fecal immunochemical test yearly or colonoscopy (from 45), and primary HPV testing every five years (30 to 65); no search for bone cancer, because nothing in her history, examination or blood tests points to one; bone health through weight-bearing and strengthening exercise, calcium from food and adequate vitamin D, with bone density testing at 65 or sooner if a risk factor appearscompletedGL-USPSTF-BRCA-2024, GL-USPSTF-CRC-2021, GL-USPSTF-CERV-2018

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Dorman PF. Hatshepsut: Wicked Stepmother or Joan of Arc? Oriental Institute News and Notes 168 (Winter 2001) The Oriental Institute, University of Chicago (Fathom Archive) scholarly
SRC-0002 Seated Statue of Hatshepsut (Rogers Fund, 1929), collection record: ca. 1473–1458 BCE, joint reign of Hatshepsut and Thutmose III, Dynasty 18, New Kingdom The Metropolitan Museum of Art (Collection API) other
SRC-0003 Egypt and Sudan Newsletter 1 (2014): Pharaoh: King of Egypt The British Museum other
SRC-0004 Rose M. Hatshepsut Found; Thutmose I Lost Archaeology (Archaeological Institute of America) other
SRC-0005 Habicht ME, Bouwman AS, Rühli FJ. Identifications of ancient Egyptian royal mummies from the 18th Dynasty reconsidered. Am J Phys Anthropol 2016;159(Suppl 61):S216-S231 (PMID 26808107) American Journal of Physical Anthropology scholarly
SRC-0006 Deadly medication? (University of Bonn press release) University of Bonn, via EurekAlert! (AAAS) other
SRC-0007 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check withholding antibiotics for a localized abscess with drainage the next day in a woman with newly found diabetes, the diagnosis of diabetes from two results in one sample, metformin then semaglutide rather than an SGLT2 inhibitor, the statin, periodontal staging and grade, and the decision not to look for bone cancer.
provenance reviewnot_startedDorman's Oriental Institute essay, a Metropolitan Museum of Art collection record, a British Museum newsletter, the Archaeology magazine report on KV60A, the 2016 review of royal mummy identifications (abstract) and the University of Bonn press release logged. No peer-reviewed paper on the KV60A CT findings was found; the Met and Smithsonian essays could not be fetched.
safe messaging reviewnot_startedFindings on the mummy are graded R because the identification is debated. Weight is discussed in person-first language and only with her permission. Ancient Egyptian culture is described plainly, without exoticizing.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.